#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1054500	F	GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM	Plasmodium falciparum	13,467	ALA1157539	organism-based format	GSK Malaria Screening
2.	ALA1054501	F	GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM	Plasmodium falciparum	13,467	ALA1157539	organism-based format	GSK Malaria Screening
3.	ALA1054502	F	GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM	Plasmodium falciparum	13,467	ALA1157539	organism-based format	GSK Malaria Screening
4.	ALA1054503	F	GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.	Plasmodium falciparum	13,467	ALA1157539	organism-based format	GSK Malaria Screening
5.	ALA1054504	F	GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.	Homo sapiens	13,467	ALA1157539	cell-based format	GSK Malaria Screening
6.	ALA1054505	F	GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested		13,467	ALA1157539	assay format	GSK Malaria Screening
7.	ALA4276029	B	Inhibition of Wnt3A-stimulated Wnt/beta-catenin pathway in HEK293 cells transfected with p8xTOPFlash, Renilla luciferase plasmid pRL-TK and pLKO.1 after 6 hrs by Dual topflash luciferase reporter assay	Homo sapiens	2	ALA4270654	cell-based format	Scientific Literature
8.	ALA4276030	B	Inhibition of Wnt/beta-catenin signaling pathway in human HCT116 cells cytosol lysate harboring beta-catenin mutation assessed as reduction in Axin2 protein expression at 5 uM after 18 hrs by Western blot analysis	Homo sapiens	2	ALA4270654	cell-based format	Scientific Literature
9.	ALA4276031	B	Inhibition of Wnt/beta-catenin signaling pathway in human HCT116 cells cytosol lysate harboring beta-catenin mutation assessed as reduction in beta-catenin protein expression at 5 uM after 18 hrs by Western blot analysis	Homo sapiens	2	ALA4270654	cell-based format	Scientific Literature
10.	ALA4276032	B	Inhibition of Wnt/beta-catenin signaling pathway in human HCT116 whole cell lysate harboring beta-catenin mutation assessed as reduction in c-Myc protein expression at 5 uM after 18 hrs by Western blot analysis	Homo sapiens	2	ALA4270654	assay format	Scientific Literature
11.	ALA4276033	B	Inhibition of Wnt/beta-catenin signaling pathway in human HCT116 whole cell lysate harboring beta-catenin mutation assessed as reduction in cyclin D1 protein expression at 5 uM after 18 hrs by Western blot analysis	Homo sapiens	2	ALA4270654	assay format	Scientific Literature
12.	ALA4276034	B	Inhibition of Wnt/beta-catenin signaling pathway in human HCT116 whole cell lysate harboring beta-catenin mutation assessed as reduction in survivin protein expression at 5 uM after 18 hrs by Western blot analysis	Homo sapiens	2	ALA4270654	assay format	Scientific Literature
13.	ALA4276035	B	Inhibition of Wnt/beta-catenin signaling pathway in human SW480 cells cytosol lysate harboring APC mutation assessed as reduction in Axin2 protein expression at 5 uM after 18 hrs by Western blot analysis	Homo sapiens	2	ALA4270654	cell-based format	Scientific Literature
14.	ALA4276036	B	Inhibition of Wnt/beta-catenin signaling pathway in human SW480 cells cytosol lysate harboring APC mutation assessed as reduction in beta-catenin protein expression at 5 uM after 18 hrs by Western blot analysis	Homo sapiens	2	ALA4270654	cell-based format	Scientific Literature
15.	ALA4276037	B	Inhibition of Wnt/beta-catenin signaling pathway in human SW480 whole cell lysate harboring APC mutation assessed as reduction in c-Myc protein expression at 5 uM after 18 hrs by Western blot analysis	Homo sapiens	2	ALA4270654	assay format	Scientific Literature
16.	ALA4276038	B	Inhibition of Wnt/beta-catenin signaling pathway in human SW480 whole cell lysate harboring APC mutation assessed as reduction in cyclin D1 protein expression at 5 uM after 18 hrs by Western blot analysis	Homo sapiens	2	ALA4270654	assay format	Scientific Literature
17.	ALA4276039	B	Inhibition of Wnt/beta-catenin signaling pathway in human SW480 whole cell lysate harboring APC mutation assessed as reduction in survivin protein expression at 5 uM after 18 hrs by Western blot analysis	Homo sapiens	2	ALA4270654	assay format	Scientific Literature
18.	ALA4276040	B	Inhibition of Wnt/beta-catenin signaling pathway in human CRC240 cells cytosol lysate assessed as reduction in Axin2 protein expression at 5 uM after 18 hrs by Western blot analysis	Homo sapiens	2	ALA4270654	cell-based format	Scientific Literature
19.	ALA4276041	B	Inhibition of Wnt/beta-catenin signaling pathway in human CRC240 cells cytosol lysate assessed as reduction in beta-catenin protein expression at 5 uM after 18 hrs by Western blot analysis	Homo sapiens	2	ALA4270654	cell-based format	Scientific Literature
20.	ALA4276042	B	Inhibition of Wnt/beta-catenin signaling pathway in human CRC240 whole cell lysate assessed as reduction in c-Myc protein expression at 5 uM after 18 hrs by Western blot analysis	Homo sapiens	2	ALA4270654	assay format	Scientific Literature